genOway Société anonyme

genOway is a biotechnology company founded in 1999 that designs and produces genetically modified mice, rats, and cell lines for preclinical research. The company offers both a catalog of translational models and custom-designed solutions, with a primary focus on immuno-oncology and immunotherapy. Its services support target validation, drug screening, efficacy testing, and non-regulatory safety testing for bio-pharmaceutical companies and academic institutions. genOway utilizes technologies including homologous recombination, nuclease-based gene editing, and recombinase-mediated cassette exchange to generate knockouts, knockins, point mutations, humanizations, and inducible models. The company provides integrated services that include phenotyping studies, physiological evaluation, and line amplification to deliver cohorts ready for experimentation. genOway serves clients across five continents, maintaining a license portfolio that guarantees freedom to operate for its customers. Its models are featured in scientific articles and are used in research areas such as T-cell engagers, antibody-drug conjugates, and tumor-immune interactions.